Neurocrine Biosciences
Speed Read
0%
300 WPM
-- remaining
Neurocrine Biosciences focuses on neurological and endocrine disorders, with approved treatments for movement disorders and women's health. The company's drug for tardive dyskinesia filled a significant unmet need. Neurocrine's focused approach to neuroscience has yielded both commercial success and pipeline growth.